Delivering mechanism-level insight into IO enhancers to help Eidolon quickly select and optimise their next-generation agents.

Sentinal4D is working with Eidolon to characterise their new immune-oncology enhancers — engineered combinations of bacterial effectors. Using our NOVAcore model we’re providing rapid, mechanism-level insight into how each effector cocktail reshapes signalling, immunity, and cell-state transitions This gives Eidolon a fast, precise foundation for selecting and optimising their next-generation IO agents